All Article Listing | RxWiki

Health News

New Perspectives on How a Killer Works

Scientists are beginnning to understand why liver cancer is so aggressive. Hong Kong researchers may have uncovered a mechanism that can effectively treat this nearly always fatal disease.

FDA Approves Rectiv For Chronic Anal Fissure Pain

ProStrakan Group plc , a subsidiary of Kyowa Hakko Kirin Co. Ltd. and an international specialty pharmaceutical company, announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Rectiv (nitroglycerin) Ointment 0.4% for the treatment of moderate to severe pain associated with chronic anal fissures.

Expecting the Flu

What should a woman expect when she's expecting? Expect a flu shot. It's safe and protective for both the mom and unborn child and it only hurts for a few seconds.

Worse Outcomes for Patients at Isolated Rural Hospitals

Patients at smaller, rural hospitals may not be getting the same quality of care as some of the larger hospitals inside major cities. A study indicates patients at these less accessible hospitals have a greater chance of dying from serious illnesses such as congestive heart failure.

The Brighter Side of Liquid Courage

Alcohol has been called “liquid courage.” This perceived benefit may outweigh all the real negative side effects for regular drinkers. Researchers are now tapping into the reason why.

Genome Project Finds Race Disparity Cause

It is known that differences among white blood cell counts vary by race or ethnicity. Scientists have recently discovered the genes responsible for those differences in white blood cell counts.

Treating More Than the Breast Cancer

Older women diagnosed with breast cancer often have other health problems which can affect their overall survival. So it's important for primary care physicians to work with oncologists to treat the whole woman.

Heart Transplant Patients Have Higher Skin Cancer Risk

Those receiving heart transplants expect there will be numerous risks from the procedure itself to infections following the operation. There may be additional, unexpected disease risks though, according to a new study.

Pfizer and Acura Announce FDA Approval of Oxecta

Pfizer Inc. and Acura Pharmaceuticals Inc. announce the marketing approval from the U.S. Food and Drug Administration (FDA) of OXECTATM (oxycodone HCl, USP) Tablets CII. OXECTA is indicated for the management of acute and chronic moderate to severe pain where the use of an opioid analgesic is appropriate.

FDA Alert For Nulojix

Bristol-Myers Squibb (BMS) informed healthcare professionals about the risk evaluation and mitigation strategy ( REMS ) that is required for Nulojix to ensure that the benefits of Nulojix outweigh the risks of post-transplant lymphoproliferative disorder ( PTLD ) and progressive m ultifocal l eukoencephalopathy ( PML ), both of which can be fatal.

REFINE